Cancer Treatment

Cellular profiling of leukapheresis and infusion products of patients enrolled in CD19 CAR T cell therapy identifies biomarkers associated with clinical outcomes

CD19 CAR T cell therapy has emerged as a promising therapy in the treatment of B cell malignancies, such as B cell acute lymphoblastic …

Chour T, Hirayama A, Zheng Y , Sheih A, Zhuang S, Wilson A, Wu V, Gottardo R, Turtle C, Gardner R, Newell E